# reload+after+2024-01-23 07:45:42.474627
address1§2 Tower Place
address2§Suite 2000
city§South San Francisco
state§CA
zip§94080
country§United States
phone§650 266 6000
website§https://www.fluidigm.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§As of January 5, 2024, Standard BioTools Inc. was acquired by SomaLogic, Inc., in a reverse merger transaction. Standard BioTools Inc., together with its subsidiaries, creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
fullTimeEmployees§523
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Michael  Egholm Ph.D.', 'age': 60, 'title': 'President, CEO & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 640342, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Hanjoon  Kim', 'age': 52, 'title': 'Chief Operating Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 468045, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeremy Steven Davis', 'title': 'Chief Commercial Officer', 'fiscalYear': 2022, 'totalPay': 468045, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stephen R. Quake D.phil., Ph.D.', 'age': 53, 'title': 'Co-Founder & Chairman of Advisory Board', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey G. Black', 'age': 54, 'title': 'Senior VP & CFO', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew  Quong Ph.D.', 'title': 'Chief Science Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Agnieszka M. Gallagher J.D.', 'age': 49, 'title': 'Senior VP & Chief Legal Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mark  Spearman', 'title': 'Senior Director of Corporate Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Elizabeth R. Jensen', 'age': 48, 'title': 'Chief Human Resources Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David A. King Ph.D.', 'title': 'Senior Vice President of Global Research & Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§3
boardRisk§3
compensationRisk§9
shareHolderRightsRisk§9
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.626
priceToSalesTrailing12Months§1.3686011
currency§USD
dateShortInterest§1702598400
forwardEps§-0.01
exchange§NMS
quoteType§EQUITY
shortName§Standard BioTools Inc.
longName§Standard BioTools Inc.
firstTradeDateEpochUtc§1297348200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a18771cf-7e18-3cdf-9dad-769d494bafef
gmtOffSetMilliseconds§-18000000
targetHighPrice§0.5
targetLowPrice§0.5
targetMeanPrice§0.5
targetMedianPrice§0.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§2.807
grossMargins§0.15574999
ebitdaMargins§-0.70178
trailingPegRatio§None
